FEDERAL SIGNAL CORP /DE/ (FSS) earnings date, results and what the price requires
NYSE · SEC CIK 0000277509 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $670.2M | $86.1M | $1.40 | Filing |
| Mar 31, 2026 | Apr 29, 2026 | $625.6M | $70.4M | $1.14 | Filing |
| Dec 31, 2025 | Feb 25, 2026 | $597.1M | $60.8M | $0.99 | Filing |
| Sep 30, 2025 | Oct 30, 2025 | $555.0M | $68.1M | $1.11 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $564.6M | $71.4M | $1.16 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $463.8M | $46.3M | $0.75 | Filing |
| Dec 31, 2024 | Feb 26, 2025 | $472.0M | $50.0M | $0.80 | Filing |
| Sep 30, 2024 | Oct 31, 2024 | $474.2M | $53.9M | $0.87 | Filing |
What would FEDERAL SIGNAL CORP /DE/ have to report for its valuation to change?
At $113.47, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 15.9% a year, to $9.70. On that path the next quarter needs diluted EPS near $1.29, against $1.11 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 15.9% | 15.9% |
| EPS needed in final year | $9.70 | $9.70 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. FSS goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.